Enzymatic Biosensors are innovative analytical devices designed to detect and quantify specific substances by leveraging the catalytic activity of enzymes. These biosensors typically consist of a biorecognition element (enzyme), a transducer, and a signal-processing system. Enzymes act as molecular catalysts, facilitating biochemical reactions with high specificity and sensitivity. The transducer converts the enzymatic reaction into a measurable signal, such as an electrical, optical, or electrochemical output. Enzymatic biosensors find widespread application in various fields, including medical diagnostics, environmental monitoring, and food safety. Their specificity allows for the precise detection of target analytes, ranging from glucose and cholesterol in clinical settings to pollutants in environmental samples. The integration of nanotechnology and microfabrication techniques has enhanced the performance and miniaturization of enzymatic biosensors. These devices offer rapid and real-time detection capabilities, making them invaluable for point-of-care diagnostics and continuous monitoring. Challenges in enzymatic biosensor development include stability and immobilization of enzymes, but ongoing research aims to address these issues. The versatility and accuracy of enzymatic biosensors contribute to their increasing importance in advancing diagnostics and monitoring applications across diverse domains.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States